A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial

Abstract

Aim The current study evaluated the feasibility and preliminary efficacy of a psychosocial intervention, the Kidney Optimal Health Program, in reducing symptoms of depression and anxiety in individuals with advanced chronic kidney disease. Methods Patients with stage 4 or 5 chronic kidney disease were randomized to either a nine‐session psychosocial intervention programme or usual care. Feasibility was assessed through recruitment and retention rates and programme acceptability. Participants completed assessments of depression, anxiety and psychosocial health at baseline and at 3‐, 6‐ and 12‐month follow‐up. A repeated‐measures analysis of variance was used to compare groups on outcomes over time. Results One hundred and twenty‐eight patients were screened for eligibility; 84 consented to participant and were randomized to receive the intervention (N = 42) or usual care (N = 42). 27 (32.1%) participants withdrew prior to baseline assessment. Of those who completed the baseline assessment (N = 57), trial retention was high (75.4% at 3‐month, 80.7% at 6‐month and 70.2% at 12‐month follow‐up). Participants reported high levels of programme acceptability. The patients who completed the intervention (N = 17) demonstrated significantly decreased depression at 12‐month follow‐up compared to the usual care group (N = 13). Conclusion The results support the feasibility of the Kidney Optimal Health Program intervention in recruitment, retention and programme acceptability with an improved screening protocol. Preliminary support is provided for improvement in depressive symptoms in patients with advanced chronic kidney disease. Further investigation through a fully powered randomized controlled trial is warranted.

What are the qualitative experiences of people affected by kidney failure receiving haemodialysis?

“…Despite an increasing number of self-management interventions tested through research (Donald et al, 2021;Jenkins et al, 2021;M. C. Lee, Wu, et al, 2021;Morris & Lycett, 2021) patients are still experiencing unmet needs in practice.…”

The application effect of the trans-theoretical model of behavior change in diabetic kidney disease patients treated with maintenance hemodialysis

“…Clinical research suggested that favorable hemodialysis requires patients to precisely control their fluid intake and diet, which greatly changes the patients' previous living habits [7][8][9][10][11][12][13][14][15][16][17][18]. Most patients refuse to receive the long-term hemodialysis treatment psychologically and therefore they tend to generate some negative moods (including depression and anxiety) [19]. As a result, they respond negatively to the treatment and behave with poor compliance, thus influencing the blood glucose control, overall treatment outcome, and prognosis [20][21][22][23][24].…”

Long COVID Optimal Health Program (LC-OHP) to Enhance Psychological and Physical Health: Protocol for a Feasibility Randomized Controlled Trial

“…This approach challenges traditional methods of health care by encouraging patients to be actively involved in their own management [56] as this is anticipated to be more effective than using passive approaches [57]. The OHP has been shown to be beneficial for people with other chronic conditions such as diabetes [58], stroke [59], and chronic kidney disease [60]. However, no research has yet evaluated its use in patients with long COVID.…”